These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16741899)

  • 21. [Preoperation risk factor analysis in orthotopic liver transplantation with pre-transplant artificial liver support therapy].
    Yuan JZ; Ye QF; Ming YZ; Hang ZF; Zhao LL; Zhao XY; Wang MM; Zhang MZ; Wen ZX; Zhu SH; Wu K
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):175-8. PubMed ID: 15760548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis.
    Bellmann R; Graziadei IW; Feistritzer C; Schwaighofer H; Stellaard F; Sturm E; Wiedermann CJ; Joannidis M
    Liver Transpl; 2004 Jan; 10(1):107-14. PubMed ID: 14755786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning.
    Kantola T; Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
    Ther Apher Dial; 2009 Oct; 13(5):399-403. PubMed ID: 19788456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes.
    Smith JO; Shiffman ML; Behnke M; Stravitz RT; Luketic VA; Sanyal AJ; Heuman DM; Fisher RA; Cotterell AH; Maluf DG; Posner MP; Sterling RK
    Liver Transpl; 2009 Mar; 15(3):273-9. PubMed ID: 19243008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the molecular adsorbent recirculating system and plasmapheresis for patients with graft dysfunction after liver transplantation.
    Lee JY; Kim SB; Chang JW; Park SK; Kwon SW; Song KW; Hwang S; Lee SG
    Transplant Proc; 2010 Sep; 42(7):2625-30. PubMed ID: 20832557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
    Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
    Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study.
    Faybik P; Krenn CG; Baker A; Lahner D; Berlakovich G; Steltzer H; Hetz H
    Liver Transpl; 2004 Aug; 10(8):1060-4. PubMed ID: 15390334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of renal failure on liver transplantation survival.
    Afonso RC; Hidalgo R; Zurstrassen MP; Fonseca LE; Pandullo FL; Rezende MB; Meira-Filho SP; Ferraz-Neto BH
    Transplant Proc; 2008 Apr; 40(3):808-10. PubMed ID: 18455024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of intractable pruritus with MARS.
    Acevedo Ribó M; Moreno Planas JM; Sanz Moreno C; Rubio González EE; Rubio González E; Boullosa Graña E; Sanchez-Turrión V; Sanz Guajardo D; Cuervas-Mons V
    Transplant Proc; 2005 Apr; 37(3):1480-1. PubMed ID: 15866646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors.
    Paugam-Burtz C; Kavafyan J; Merckx P; Dahmani S; Sommacale D; Ramsay M; Belghiti J; Mantz J
    Liver Transpl; 2009 May; 15(5):522-9. PubMed ID: 19399736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of early burn-induced effects on liver function as reflected by the plasma disappearance rate of indocyanine green: a prospective descriptive cohort study.
    Steinvall I; Fredrikson M; Bak Z; Sjoberg F
    Burns; 2012 Mar; 38(2):214-24. PubMed ID: 22040928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation.
    Campbell MS; Rai J; Kozin E; Bloom RD; Markmann JF; Olthoff KM; Shaked A; Rajender Reddy K
    Clin Transplant; 2007; 21(3):377-84. PubMed ID: 17488388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indocyanine green dye clearance test: early graft (dys)-function and long-term mortality after liver transplant. Should we continue to use it? An observational study.
    Cherchi V; Vetrugno L; Zanini V; Isler T; Pravisani R; Borghi A; Baccarani U; Terrosu G; Risaliti A; Bove T
    J Clin Monit Comput; 2021 May; 35(3):505-513. PubMed ID: 32166552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of an adult with Amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS).
    Lionte C; Sorodoc L; Simionescu V
    Rom J Gastroenterol; 2005 Sep; 14(3):267-71. PubMed ID: 16200238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver support therapy with molecular adsorbents recirculating system in liver failure: a summary of 252 cases from 14 centers in China.
    Wang MM; Chen SJ; Ye QF; Yang YJ; Chen SB; Zhou XM; Guo LM; Zhang YX; Ding XQ; Hu XB; Luo HT; Liu YH; Wang WY
    Chin Med J (Engl); 2008 Nov; 121(21):2197-201. PubMed ID: 19080184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure.
    de Liguori Carino N; O'Reilly DA; Dajani K; Ghaneh P; Poston GJ; Wu AV
    Eur J Surg Oncol; 2009 Sep; 35(9):957-62. PubMed ID: 19250796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of maintaining normal serum albumin level following living related liver transplantation: does serum albumin level affect the course? A pilot study.
    Mukhtar A; EL Masry A; Moniem AA; Metini M; Fayez A; Khater YH
    Transplant Proc; 2007 Dec; 39(10):3214-8. PubMed ID: 18089356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
    De Simone P; Metselaar HJ; Fischer L; Dumortier J; Boudjema K; Hardwigsen J; Rostaing L; De Carlis L; Saliba F; Nevens F
    Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial liver support system in acute liver failure patients waiting liver transplantation.
    Montejo González JC; Catalán González M; Meneu Díaz JC; Moreno Elola-Olaso A; De la Cruz J; Moreno González E
    Hepatogastroenterology; 2009; 56(90):456-61. PubMed ID: 19579620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin.
    Yang WS; Tan HK; Lui HF; Chow PK; Choong HL; Wong KS
    Artif Organs; 2008 May; 32(5):411-6. PubMed ID: 18471171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.